Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC, 3197-3198 [2021-00647]
Download as PDF
<![CDATA[
3197
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
khammond on DSKJM1Z7X2PROD with NOTICES
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Extension with change of a currently
approved collection.
2. The Title of the Form/Collection:
Records and Supporting Data:
Importation, Receipt, Storage, and
Disposition by Explosives Importers,
Manufacturers, Dealers, and Users
Licensed Under Title 18 U.S.C. Chapter
40 Explosives.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): None.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other (if applicable): None.
Abstract: This information collection
requires the maintenance of records
showing daily activities in the
importation, manufacture, receipt,
storage, and disposition of all explosive
materials covered under 18 U.S.C.
Chapter 40 Explosives. These records
must also show where and to whom
explosive materials are sent, thereby
ensuring that any diversions will be
readily apparent, and that ATF will be
immediately notified if these materials
are lost or stolen.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 9,411
respondents will prepare records for
this information collection annually,
and it will take each respondent
approximately 12.6 hours to prepare the
required records.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
592,893 hours, which is equal to 47,055
VerDate Sep<11>2014
03:30 Jan 14, 2021
Jkt 253001
(# of annual responses) * 12.6 (# of
hours per response).
7. An Explanation of the Change in
Estimates: The adjustments associated
with this collection include a decrease
in the number of respondents, responses
and total burden hours by 516, 2,580,
and 32,508 hours respectively, since the
last IC renewal in 2017.
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
following basic class of controlled
substance:
Controlled substance
Ecgonine .......................
Drug
code
9180
Schedule
II
The company plans to produce the
listed controlled substance in bulk to be
used in the manufacture of DEA exempt
products. No other activities for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–00648 Filed 1–13–21; 8:45 am]
Dated: January 11, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
BILLING CODE P
[FR Doc. 2021–00743 Filed 1–13–21; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–02–P
[Docket No. DEA–766]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Bulk Manufacturer of Controlled
Substances Application: Siemens
Healthcare Diagnostics Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Siemens Healthcare
Diagnostics Inc. has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplemental
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 15, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 15, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on December 11, 2020,
Siemens Healthcare Diagnostics Inc.,
100 GBC Drive, Mailstop 514, Newark,
Delaware 19702–2461, applied to be
registered as a bulk manufacturer of the
SUPPLEMENTARY INFORMATION:
Frm 00089
Fmt 4703
Bulk Manufacturer of Controlled
Substances Application: IsoSciences,
LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
[Docket No. DEA–768]
PO 00000
DEPARTMENT OF JUSTICE
Sfmt 4703
IsoSciences, LLC has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 15, 2021. Such persons
may also file a written request for a
hearing on the application on or before
March 15, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2020,
IsoSciences, LLC, 340 Mathers Road,
Ambler, Pennsylvania 19002–3420,
applied to be registered as an bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
Controlled substance
Cathinone ................................
Methcathinone ........................
Lysergic acid diethylamide .....
Marihuana ...............................
E:\FR\FM\14JAN1.SGM
14JAN1
Drug
code
1235
1237
7315
7360
Schedule
I
I
I
I
3198
Federal Register / Vol. 86, No. 9 / Thursday, January 14, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Tetrahydrocannabinols ...........
3,4-Methylene
dioxyamphetamine.
3,4-Methylenedioxy-Nethylamphetamine.
3,4-Methylene
dioxymethamphetamine.
5-Methoxy-N–Ndimethyltryptamine.
Alpha-methyltryptamine ..........
Bufotenine ...............................
Diethyltryptamine ....................
Dimethyltryptamine .................
Psilocybin ................................
Psilocyn ...................................
5-Methoxy-N,Ndiisopropyltryptamine.
Dihydromorphine .....................
Heroin .....................................
Nicocodeine ............................
Nicomorphine ..........................
Normorphine ...........................
Thebacon ................................
Normethadone ........................
Acryl fentanyl (N-(1phenethylpiperidin-4-yl)-Nphenylacrylamide).
Para-Fluorofentanyl ................
3-Methylfentanyl ......................
Alpha-methylfentanyl ..............
Acetyl-alpha-methylfentanyl ....
N-(2-fluorophenyl)-N-(1phenethylpiperidin-4yl)propionamide.
Acetyl Fentanyl (N-(1phenethylpiperidin-4-yl)-Nphenylacetamide).
Butyryl Fentanyl ......................
4-Fluoroisobutyryl fentanyl (N(4-fluorophenyl)-N-(1phenethylpiperidin-4yl)isobutyramide).
2-methoxy-N-(1phenethylpiperidin-4-yl)-Nphenylacetamide.
Beta-hydroxyfentanyl ..............
Beta-hydroxy-3-methylfentanyl
Alpha-methylthiofentanyl .........
3-Methylthiofentanyl ................
Furanyl fentanyl (N-(1phenethylpiperidin-4-yl)-Nphenylfuran-2-carboxamide).
Thiofentanyl ............................
Beta-hydroxythiofentanyl ........
N-(1-phenethylpiperidin-4-yl)N-phenyltetrahydrofuran-2carboxamide.
Amphetamine ..........................
Methamphetamine ..................
Codeine ...................................
Dihydrocodeine .......................
Oxycodone ..............................
Hydromorphone ......................
Hydrocodone ...........................
Isomethadone .........................
Methadone ..............................
Methadone intermediate .........
Morphine .................................
Thebaine .................................
Levo-alphacetylmethadol ........
Oxymorphone .........................
Thiafentanil .............................
Alfentanil .................................
Sufentanil ................................
Carfentanil ...............................
Fentanyl ..................................
Drug
code
Schedule
7370
7400
I
I
7404
I
7405
I
William T. McDermott,
Assistant Administrator.
7431
I
[FR Doc. 2021–00647 Filed 1–13–21; 8:45 am]
7432
7433
7434
7435
7437
7438
7439
I
I
I
I
I
I
I
9145
9200
9309
9312
9313
9315
9635
9811
I
I
I
I
I
I
I
I
9812
9813
9814
9815
9816
I
I
I
I
I
9821
I
9822
9824
I
I
9825
I
9830
9831
9832
9833
9834
I
I
I
I
I
9835
9836
9843
I
I
I
1100
1105
9050
9120
9143
9150
9193
9226
9250
9254
9300
9333
9648
9652
9729
9737
9740
9743
9801
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
BILLING CODE P
The company plans to manufacture
bulk controlled substances for use in
analytical testing. In reference to drug
codes 7360 (Marihuana) and 7370
VerDate Sep<11>2014
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetics. No other activities for
these drug codes are authorized for this
registration.
23:48 Jan 13, 2021
Jkt 253001
DEPARTMENT OF JUSTICE
[OMB Number 1121–0269]
Agency Information Collection
Activities: Proposed Collection;
Comments Requested; Reinstatement,
With Change, of a Previously
Approved Collection for Which
Approval Has Expired: 2020 Census of
Publicly Funded Forensic Crime
Laboratories (CPFFCL)
Bureau of Justice Statistics,
Department of Justice.
ACTION: 60-day notice.
AGENCY:
The Department of Justice
(DOJ), Office of Justice Programs,
Bureau of Justice Statistics, will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 60 days until March
15, 2021.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Connor Brooks, Statistician, Law
Enforcement Statistics Unit, Bureau of
Justice Statistics, 810 Seventh Street
NW, Washington, DC 20531 (email:
Connor.Brooks@usdoj.gov; phone: 202–
514–8633).
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
SUMMARY:
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Reinstatement of the Census of Publicly
Funded Forensic Crime Laboratories,
with changes, of a previously approved
collection for which approval has
expired.
(2) The Title of the Form/Collection:
2020 Census of Publicly Funded
Forensic Crime Laboratories.
(3) The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
The form number is CFCL–20. The
applicable component within the
Department of Justice is the Bureau of
Justice Statistics, Office of Justice
Programs.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
This information collection is a
census of federal, state, and local
publicly funded forensic crime
laboratories that analyze criminal
evidence. This data collection follows
the 2014 study and will collect
information on personnel, budgets,
workloads, policies, and procedures of
crime laboratories. BJS plans to field the
2020 CPFFCL from May to October
2021. The census form was assessed by
practitioners and subject matter experts
to update it from the 2014 form and
ensure its relevance to forensic crime
laboratories as well as reduce
respondent burden. The form was then
cognitively tested with 23 forensic
crime laboratories of different sizes,
regions, and government levels. In
addition to collecting detailed data for
the 2020 reference year, CPFFCL will
also collect summary data for the 2019
reference year.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: A projected 500 respondents
will take an average of 2.5 hours each
to complete form, including time to
research or find information not readily
E:\FR\FM\14JAN1.SGM
14JAN1
]]>Agencies
[Federal Register Volume 86, Number 9 (Thursday, January 14, 2021)]
[Notices]
[Pages 3197-3198]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00647]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-766]
Bulk Manufacturer of Controlled Substances Application:
IsoSciences, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: IsoSciences, LLC has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTAL INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before March 15, 2021.
Such persons may also file a written request for a hearing on the
application on or before March 15, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on November 11, 2020, IsoSciences, LLC, 340 Mathers
Road, Ambler, Pennsylvania 19002-3420, applied to be registered as an
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Cathinone.............................. 1235 I
Methcathinone.......................... 1237 I
Lysergic acid diethylamide............. 7315 I
Marihuana.............................. 7360 I
[[Page 3198]]
Tetrahydrocannabinols.................. 7370 I
3,4-Methylenedioxyamphetamine.......... 7400 I
3,4-Methylenedioxy-N-ethylamphetamine.. 7404 I
3,4-Methylenedioxymethamphetamine...... 7405 I
5-Methoxy-N-N-dimethyltryptamine....... 7431 I
Alpha-methyltryptamine................. 7432 I
Bufotenine............................. 7433 I
Diethyltryptamine...................... 7434 I
Dimethyltryptamine..................... 7435 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine.... 7439 I
Dihydromorphine........................ 9145 I
Heroin................................. 9200 I
Nicocodeine............................ 9309 I
Nicomorphine........................... 9312 I
Normorphine............................ 9313 I
Thebacon............................... 9315 I
Normethadone........................... 9635 I
Acryl fentanyl (N-(1-phenethylpiperidin- 9811 I
4-yl)-N-phenylacrylamide).
Para-Fluorofentanyl.................... 9812 I
3-Methylfentanyl....................... 9813 I
Alpha-methylfentanyl................... 9814 I
Acetyl-alpha-methylfentanyl............ 9815 I
N-(2-fluorophenyl)-N-(1- 9816 I
phenethylpiperidin-4-yl)propionamide.
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl....................... 9822 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-
4-yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)- 9825 I
N-phenylacetamide.
Beta-hydroxyfentanyl................... 9830 I
Beta-hydroxy-3-methylfentanyl.......... 9831 I
Alpha-methylthiofentanyl............... 9832 I
3-Methylthiofentanyl................... 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-phenylfuran-
2-carboxamide).
Thiofentanyl........................... 9835 I
Beta-hydroxythiofentanyl............... 9836 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Isomethadone........................... 9226 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Morphine............................... 9300 II
Thebaine............................... 9333 II
Levo-alphacetylmethadol................ 9648 II
Oxymorphone............................ 9652 II
Thiafentanil........................... 9729 II
Alfentanil............................. 9737 II
Sufentanil............................. 9740 II
Carfentanil............................ 9743 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in analytical testing. In reference to drug codes 7360 (Marihuana) and
7370 (Tetrahydrocannabinols), the company plans to bulk manufacture
these drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-00647 Filed 1-13-21; 8:45 am]
BILLING CODE P
